We have shown CAV1 to be significantly dysregulated across more than 67% of cases of mature T-cell lymphomas as well as in aggressive cases of chronic lymphocytic leukemia. The gene discussed is CAV1; the disease is B-cell chronic lymphocytic leukemia.